Recombinant FSH for ovulation induction in women with polycystic ovary syndrome: a comparison with urinary gonadotrophins and a comparison of different dose regimens

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Share/Save